Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma. - Glen C; Dobbin SJH; Mangion K; Henderson A; Brooksbank K; Coats CJ; Epstein FH; Kellman P; Butler E; Evans TRJ; Jones R; McClure J; et al. (JACC. CardioOncology, 2025)